Robert Wood Johnson Foundation

Menu
  • About RWJF
  • Our Work
  • Research & Publications
View All:
  • Grants
  • Topics
  • Blogs

Prescription Drugs and Services

You are now viewing 1 - 10 of 22 results

Sort results by:
  • Relevance
  • Alphabetical Order
  • Publication Date

Refine Your Results

  • Topic: Prescription drugs and services
  • Topic: Public policy and regulation
By Topic
  • Health policy (9)
  • Health care system (7)
  • Substance abuse treatment (6)
  • Cost of care (5)
  • Government, policy and legal issues (5)
  • Drugs (illegal and Rx) (5)
  • Federal government (4)
  • State government (4)
  • Financial barriers to care (4)
  • Quality of care (4)
  • Patient-centered care/family-centered care (3)
  • Patient-provider collaboration (3)
  • E-patients (3)
  • Observations of daily living (3)
  • Personal health monitoring (3)
By Content
  • Content Type
    • Program Result Report (9)
    • Journal Article (5)
    • Story (4)
    • Issue Brief (3)
    • Commentary (1)
  • Program Area
    • Human Capital (7)
    • Vulnerable Populations (6)
    • Quality/Equality (5)
    • Pioneer (4)
    • Public Health (2)
    • Coverage (1)
By Demographics
  • Age
    • Seniors (65+) (2)
    • Adults (19-64 years) (1)
  • Race/Ethnicity
    • Asian/Pacific Islander (1)
  • Location
    • National (11)
    • Urban (1)
  • States and Territories
    • Oregon (OR) P (1)
    • Washington (WA) P (1)

More Nonelderly Americans Face Problems Affording Prescription Drugs

January 1, 2009 | Issue Brief

More children and working-age Americans are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).

Investigator Award Recipient Calls on Government to Reform Drug Ads In New Paper

December 13, 2009 | Story

Dominick Frosch says drug ads carry 'significant risks.'

Cost, Lack of Insurance Coverage, Anti-Medication Bias Limit Scripts of Naltrexone for Alcoholism

December 9, 2005 | Program Result Report

Richard A. Rawson, Ph.D., evaluated the reasons why naltrexone (a medication-based treatment for alcohol abuse and dependence and opiate addiction) is not widely used by physicians and practitioners.

Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999-2010

March 1, 2013 | Journal Article

Increases in the prevalence of drug-resistant pneumonia present a major infection control challenge for public health.

Access to Prescription Drugs for Medicare Beneficiaries

March 1, 2009 | Issue Brief

Despite the introduction of a Medicare outpatient prescription drug benefit in January 2006, roughly the same proportion of elderly Medicare beneficiaries in 2003 and 2007--about 8 percent--skipped filling at least one prescription drug because of cost concerns, according to a new national study by the Center for Studying Health System Change.

State Prescription Drug Price Web Sites

February 1, 2008 | Issue Brief

How Useful to Consumers?

RWJF Investigator in Health Policy Research, Daniel Carpenter, PhD, Publishes New Book on the FDA

February 24, 2011 | Story

In 2003, he received an RWJF Investigator Award in Health Policy Research to probe more deeply into pharmaceutical policy at the FDA. The pursuit quickly broadened.

Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation

December 21, 2009 | Journal Article

Policy innovations to stimulate drug development succeed, but sometimes with unintended consequences.

Medications Work for Severely Addicted Smokers

January 1, 2005 | Commentary

Previous research has demonstrated that individuals who are severely addicted to cigarettes may have more difficulty quitting, higher rates of relapse and greater risk of smoking-related diseases than lighter smokers. The effectiveness of current to ...

Pharmacotherapy for Nicotine Dependence

September 1, 2005 | Journal Article

Pharmacotherapies for smoking reduction and cessation can play a vital role in helping individuals quit smoking. This article summarizes the current rates of smoking and smoking-related disease in the United States, outlines the projected benefits o ...

  • 1
  • 2
  • 3
  • Next
RWJF Home → Topics → Prescription Drugs and Services
  • Facebook
  • Twitter
  • YouTube
  • Email
  • RSS

Our mission: to improve the health and health care of all Americans.

  • About RWJF
    • Our Mission
    • Program Areas
    • From Our President
    • Leadership & Staff
    • Annual Reports
    • Newsroom
    • Job Opportunities
    • Office Location
    • Our Policies
  • Our Work
    • Health Policy
    • Prevention
    • Cost and Value
    • Leadership
    • All Topics
  • Program Areas
    • Childhood Obesity
    • Coverage
    • Human Capital
    • Pioneer
    • Public Health
    • Quality/Equality
    • Vulnerable Populations
  • Research & Publications
    • Find RWJF Research
    • Assessing Our Impact
    • How We Work
    • Data Center
    • RWJF DataHub
  • Grants
    • What We Fund
    • Calls for Proposals
    • Grantee Resources
    • FAQs
  • Blogs
    • Human Capital
    • New Public Health
    • Pioneering Ideas
  • My RWJF
    • Subscription Management
    • My Profile
  • Contact RWJF
  • Privacy Policy
  • Terms and Conditions

© 2001–2013 Robert Wood Johnson Foundation. All Rights Reserved.